Header Logo

Connection

PREMAL LULLA to Drug Resistance, Neoplasm

Back to Details
This is a "connection" page, showing publications PREMAL LULLA has written about Drug Resistance, Neoplasm.
PREMAL LULLA
Connection Strength
0.108
Drug Resistance, Neoplasm
  1. The use of chimeric antigen receptor T cells in patients with non-Hodgkin lymphoma. Clin Adv Hematol Oncol. 2018 May; 16(5):375-386.
    View in: PubMed
    Score: 0.108
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.